Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Receivables - Net (2016 - 2024)

Historic Receivables - Net for Dare Bioscience (DARE) over the last 9 years, with Q4 2024 value amounting to $700000.0.

  • Dare Bioscience's Receivables - Net changed N/A to $700000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $700000.0, marking a year-over-year change of. This contributed to the annual value of $700000.0 for FY2024, which is N/A changed from last year.
  • Dare Bioscience's Receivables - Net amounted to $700000.0 in Q4 2024.
  • Over the past 5 years, Dare Bioscience's Receivables - Net peaked at $49.0 million during Q2 2021, and registered a low of $12000.0 during Q4 2020.
  • For the 4-year period, Dare Bioscience's Receivables - Net averaged around $8.6 million, with its median value being $428000.0 (2020).
  • In the last 5 years, Dare Bioscience's Receivables - Net skyrocketed by 2924131.74% in 2021 and then tumbled by 7959.18% in 2022.
  • Over the past 4 years, Dare Bioscience's Receivables - Net (Quarter) stood at $12000.0 in 2020, then soared by 408233.33% to $49.0 million in 2021, then crashed by 79.59% to $10.0 million in 2022, then crashed by 93.0% to $700000.0 in 2024.
  • Its Receivables - Net was $700000.0 in Q4 2024, compared to $10.0 million in Q2 2022 and $49.0 million in Q2 2021.